Beckman, Joshua
( UT Southwestern
, Dallas
, Texas
, United States
)
Landmesser, Ulf
( DZHK
, Berlin
, Germany
)
Author Disclosures:
Joshua Beckman:DO have relevant financial relationships
;
Consultant:Medtronic:Active (exists now)
; Consultant:Novo Nordisk:Active (exists now)
; Consultant:Tourmaline:Active (exists now)
; Consultant:Regeneron:Active (exists now)
; Consultant:Novo Nordis:Active (exists now)
; Consultant:Novartis:Active (exists now)
; Consultant:Minsight:Active (exists now)
; Consultant:Merck:Active (exists now)
| Ulf Landmesser:DO have relevant financial relationships
;
Research Funding (PI or named investigator):Abbott:Active (exists now)
; Research Funding (PI or named investigator):Novartis:Active (exists now)
; Research Funding (PI or named investigator):Bayer:Expected (by end of conference)
; Research Funding (PI or named investigator):Amgen:Expected (by end of conference)